FDA Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers – New York Times

06. April 2017 Health, HIPAA 0

New York Times

FDA Will Allow 23andMe to Sell Genetic Tests for Disease Risk to Consumers
New York Times
23andMe headquarters in Mountain View, Calif. The Food and Drug Administration said on Thursday that it would allow the company to sell genetic tests directly to consumers. Credit Kristoffer Tripplaar/Sipa Press. For the first time, the Food and Drug …
FDA Approves 23andMe’s At-Home DNA Tests for 10 DiseasesNBCNews.com
At-home genetic test for 10 diseases gets first FDA approvalCNN
23andMe Rides Again: FDA Clears Genetic Tests To Predict Disease RiskForbes
PR Newswire (press release) –The Verge –Gizmodo –FDA.gov
all 63 news articles »

Powered by WPeMatico